The preference of putative pro-enkephalins for different types of opiate receptors.
D000818:Animals; D001575:Benzomorphans / Q000031:analogs & derivatives / Q000494:pharmacology; D001921:Brain / Q000378:metabolism; D004361:Drug Tolerance; D004399:Dynorphins; D004723:Endorphins / Q000378:metabolism*; D016308:Enkephalin, Leucine-2-Alanine; D004744:Enkephalin, Methionine / Q000031:analogs & derivatives*; D004745:Enkephalins / Q000378:metabolism* / Q000494:pharmacology; D005283:Fentanyl / Q000494:pharmacology; D006168:Guinea Pigs; D007082:Ileum / Q000378:metabolism; D008297:Male; D051379:Mice; D009020:Morphine / Q000494:pharmacology; D011498:Protein Precursors / Q000378:metabolism*; D051381:Rats; D011957:Receptors, Opioid / Q000187:drug effects / Q000378:metabolism*; D014649:Vas Deferens / Q000378:metabolism
D001575:Benzomorphans; D004723:Endorphins; D004745:Enkephalins; D011498:Protein Precursors; D011957:Receptors, Opioid; C032478:MR 2034; D004744:Enkephalin, Methionine; D016308:Enkephalin, Leucine-2-Alanine; C025681:alpha-neoendorphin; C027511:enkephalin-Met, Arg(6)-Phe(7)-; D004399:Dynorphins; D009020:Morphine; C032479:MRZ 2549; D005283:Fentanyl